ZMapp FDA Approval Status
FDA Approved: No
Brand name: ZMapp
Company: Mapp Biopharmaceutical, Inc.
Treatment for: Ebola Virus Disease
ZMapp is a combination of three chimeric monoclonal antibodies manufactured in the Nicotiana benthamiana tobacco plant. It has been used in the experimental treatment of Ebola virus disease.
Development timeline for ZMapp
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
